Los Angeles Capital Management LLC Night Hawk Biosciences, Inc. Transaction History

Los Angeles Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$3.04 - $6.01 $31,388 - $62,053	-10,325 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$5.9 - $7.44 $23,157 - $29,202	-3,925 Reduced 27.54%	10,325 $61,000
Q1 2021 May 05, 2021	SELL	$5.67 - $12.54 $23,360 - $51,664	-4,120 Reduced 22.43%	14,250 $103,000
Q4 2020 Feb 04, 2021	BUY	$5.28 - $9.59 $96,993 - $176,168	18,370 New	18,370 $98,000

48.5K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.